Page last updated: 2024-09-03

gefitinib and Cholangitis

gefitinib has been researched along with Cholangitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, NS; Li, FY; Ma, WJ; Mao, H; Shrestha, A; Yang, Q; Zhang, W; Zhou, Y	1

Other Studies

1 other study(ies) available for gefitinib and Cholangitis

Article	Year
Effects of epidermal growth factor receptor inhibitor on proliferative cholangitis in hepatolithiasis. Hepatobiliary & pancreatic diseases international : HBPD INT, 2015, Volume: 14, Issue:5 Topics: Adult; Aged; Bile Ducts; Cholangitis; Collagen Type I; Endoscopy, Digestive System; Epithelium; ErbB Receptors; Female; Gefitinib; Gene Expression; Glucuronidase; Humans; Hyperplasia; Ki-67 Antigen; Lithiasis; Liver Diseases; Male; Middle Aged; Mucin-3; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Quinazolines	2015

Article

Year

Effects of epidermal growth factor receptor inhibitor on proliferative cholangitis in hepatolithiasis.

Hepatobiliary & pancreatic diseases international : HBPD INT, 2015, Volume: 14, Issue:5

Topics: Adult; Aged; Bile Ducts; Cholangitis; Collagen Type I; Endoscopy, Digestive System; Epithelium; ErbB Receptors; Female; Gefitinib; Gene Expression; Glucuronidase; Humans; Hyperplasia; Ki-67 Antigen; Lithiasis; Liver Diseases; Male; Middle Aged; Mucin-3; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Quinazolines

2015